Concepedia

Robert Gottlieb

RG

Statistics

Publications

68

Citations

10K

H-Index

36

Active since

1984

Affiliations

Baylor University Medical Center(Current)

Baylor Medical Center at Garland

Gilead Sciences (United States)

Baylor Scott & White Health

Harvard University

Robert Gottlieb is an author at Baylor University Medical Center specializing in infectious diseases, pharmacotherapy, and pharmacy.

ORCID

Publications per year

1984–2025

68

Publications

68

SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19

Peter Chen, Ajay Nirula, Barry N. Heller et al. · New England Journal of Medicine · 2020 · 1.4K citations · Full text

, , +14

The New Yorker

Robert Gottlieb · ˜The œNew Yorker · 1987 · 1.3K citations

Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients

Robert Gottlieb, Carlos Vaca, Roger Paredes et al. · New England Journal of Medicine · 2021 · 1.3K citations · Full text

, , +13

Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19

Christoph D. Spinner, Robert Gottlieb, Gerard J. Criner et al. · JAMA · 2020 · 1.3K citations · Full text

, , +9

Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19

Robert Gottlieb, Ajay Nirula, Peter Chen et al. · JAMA · 2021 · 947 citations · Full text

, , +15

1–5 of 68